Sophia Randolph, Chief Medical Officer at ALX ONCOLOGY HOLDINGS INC (ALXO), sold 13,231 shares at $59.15 ($785K) on 2021-04-12, disclosed to the SEC on 2021-04-13.
Open-market sale of $785k ALXO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.06 | 2,903 | $169K | 21.5% |
| 2 | $58.06 | 2,903 | $169K | 21.5% |
| 3 | $59.15 | 1,000 | $59K | 7.5% |
| 4 | $60.29 | 2,941 | $177K | 22.6% |
| 5 | $60.29 | 2,941 | $177K | 22.6% |
| 6 | $61.59 | 259 |
| $16K |
| 2.0% |
| 7 | $63.51 | 284 | $18K | 2.3% |
| Total | $59.32 avg | 13,231 | $785K | 100% |
| Filing → |
| ALXO | SELL | 2024-05-15 | $353K | — | Filing → |
| ALXO | SELL | 2024-01-03 | $47K | — | Filing → |
| ALXO | SELL | 2023-07-05 | $12K | — | Filing → |